Optimal Scan Time of 18F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report (Q36194533)

12 August 2017

0 references

Optimal Scan Time of 18F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report (English)

1 reference

12 August 2017

Wen-Qian Zhang

1

1 reference

12 August 2017

Yi-Li Fu

2

1 reference

12 August 2017

Bin Hu

3

1 reference

12 August 2017

Shuo Chen

4

1 reference

12 August 2017

Min-Fu Yang

5

1 reference

12 August 2017

Hui Li

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2015

1 reference

12 August 2017

1 reference

12 August 2017

94

1 reference

12 August 2017

24

1 reference

12 August 2017

e884

1 reference

The normal variant (18)F FDG uptake in the lower thoracic spinal cord segments in cancer patients without CNS malignancy

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Radiofrequency ablation of lung tumours

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

1 October 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the Europ

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Appropriate surgical treatment of resectable non-small-cell lung cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Radiofrequency ablation of lung metastases: factors influencing success.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4616549

Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning

22 September 2018

1 reference

12 December 2020

Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study

1 reference

12 December 2020

Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings

1 reference

12 December 2020

Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence

1 reference

12 December 2020

Percutaneous radiofrequency ablation of malignancies in the lung

1 reference

12 December 2020

10.1097/MD.0000000000000884

Identifiers

DOI

1 reference

release_fejctqrkqbgdpdmjhcwbzwypiq

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fejctqrkqbgdpdmjhcwbzwypiq

24 November 2022

mapped directly with Wikidata item

1 reference

12 August 2017

PubMed publication ID

26091453

1 reference